|
1
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen Z, Liu H, Jin W, Ding Z, Zheng S and
Yu Y: Tissue microRNA-21 expression predicted recurrence and poor
survival in patients with colorectal cancer-a meta-analysis. Onco
Targets Ther. 9:2615–2624. 2016.PubMed/NCBI
|
|
3
|
Gao Y, Cai Q, Huang Y, Li S, Yang H, Sun
L, Chen K and Wang Y: MicroRNA-21 as a potential diagnostic
biomarker for breast cancer patients: A pooled analysis of
individual studies. Oncotarget. 7:34498–34506. 2016.PubMed/NCBI
|
|
4
|
Wu ZH, Tao ZH, Zhang J, Li T, Ni C, Xie J,
Zhang JF and Hu XC: MiRNA-21 induces epithelial to mesenchymal
transition and gemcitabine resistance via the PTEN/AKT pathway in
breast cancer. Tumour Biol. 37:7245–7254. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hu GY, Tao F, Wang W and Ji KW: Prognostic
value of microRNA-21 in pancreatic ductal adenocarcinoma: A
meta-analysis. World J Surg Oncol. 14:822016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang S, Wang R, Yan H, Jin L, Dou X and
Chen D: MicroRNA-21 modulates radiation resistance through
upregulation of hypoxia-inducible factor-1α-promoted glycolysis in
non-small cell lung cancer cells. Mol Med Rep. 13:4101–4107. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yan J, Liu T, Zhou X, Dang Y, Yin C and
Zhang G: FZD6, targeted by miR-21, represses gastric cancer cell
proliferation and migration via activating non-canonical wnt
pathway. Am J Transl Res. 8:2354–2364. 2016.PubMed/NCBI
|
|
8
|
Tao YJ, Li YJ, Zheng W, Zhao JJ, Guo MM,
Zhou Y, Qin NL, Zheng J and Xu L: Antisense oligonucleotides
against microRNA-21 reduced the proliferation and migration of
human colon carcinoma cells. Cancer Cell Int. 15:772015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sha M, Ye J, Luan ZY, Guo T, Wang B and
Huang JX: Celastrol induces cell cycle arrest by
MicroRNA-21-mTOR-mediated inhibition p27 protein degradation in
gastric cancer. Cancer Cell Int. 15:1012015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Husakova M: MicroRNAs in the key events of
systemic lupus erythematosus pathogenesis. Biomed Pap Med Fac Univ
Palacky Olomouc Czech Repub. 160:327–342. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sanders KA, Benton MC, Lea RA, Maltby VE,
Agland S, Griffin N, Scott RJ, Tajouri L and Lechner-Scott J:
Next-generation sequencing reveals broad down-regulation of
microRNAs in secondary progressive multiple sclerosis CD4+ T cells.
Clin Epigenetics. 8:872016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao XY and Shao K: Roles of MicroRNA-21
in the pathogenesis of insulin resistance and diabetic
mellitus-induced non-alcoholic fatty liver disease. Zhongguo Yi Xue
Ke Xue Yuan Xue Bao. 38:144–149. 2016.(In Chinese). PubMed/NCBI
|
|
13
|
Sekar D, Venugopal B, Sekar P and
Ramalingam K: Role of microRNA 21 in diabetes and
associated/related diseases. Gene. 582:14–18. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo Q, Zhang H, Zhang L, He Y, Weng S,
Dong Z, Wang J, Zhang P and Nao R: MicroRNA-21 regulates non-small
cell lung cancer cell proliferation by affecting cell apoptosis via
COX-19. Int J Clin Exp Med. 8:8835–8841. 2015.PubMed/NCBI
|
|
15
|
Li X, Zang A, Jia Y, Zhang J, Fan W, Feng
J, Duan M, Zhang L, Huo R, Jiao J and Zhu X: Triptolide reduces
proliferation and enhances apoptosis of human non-small cell lung
cancer cells through PTEN by targeting miR-21. Mol Med Rep.
13:2763–2768. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang Y, Meng H, Peng Q, Yang X, Gan R,
Zhao L, Chen Z, Lu J and Meng QH: Downregulation of microRNA-21
expression restrains non-small cell lung cancer cell proliferation
and migration through upregulation of programmed cell death 4.
Cancer Gene Ther. 22:23–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Boldrini L, Giordano M, Ali G, Melfi F,
Romano G, Lucchi M and Fontanini G: P2X7 mRNA expression in
non-small cell lung cancer: MicroRNA regulation and prognostic
value. Oncol Lett. 9:449–453. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yan LX, Liu YH, Xiang JW, Wu QN, Xu LB,
Luo XL, Zhu XL, Liu C, Xu FP, Luo DL, et al: PIK3R1 targeting by
miR-21 suppresses tumor cell migration and invasion by reducing
PI3K/AKT signaling and reversing EMT, and predicts clinical outcome
of breast cancer. Int J Oncol. 48:471–484. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Saito M, Schetter AJ, Mollerup S, Kohno T,
Skaug V, Bowman ED, Mathé EA, Takenoshita S, Yokota J, Haugen A and
Harris CC: The association of microRNA expression with prognosis
and progression in early-stage, non-small cell lung adenocarcinoma:
A retrospective analysis of three cohorts. Clin Cancer Res.
17:1875–1882. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rami-Porta R, Crowley JJ and Goldstraw P:
The revised TNM staging system for lung cancer. Ann Thorac
Cardiovasc Surg. 15:4–9. 2009.PubMed/NCBI
|
|
22
|
Zhu W and Xu B: MicroRNA-21 identified as
predictor of cancer outcome: A meta-analysis. PLoS One.
9:e1033732014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma XL, Liu L, Liu XX, Li Y, Deng L, Xiao
ZL, Liu YT, Shi HS and Wei YQ: Prognostic role of microRNA-21 in
non-small cell lung cancer: A meta-analysis. Asian Pac J Cancer
Prev. 13:2329–2334. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cinegaglia NC, Andrade SC, Tokar T,
Pinheiro M, Severino FE, Oliveira RA, Hasimoto EN, Cataneo DC,
Cataneo AJ, Defaveri J, et al: Integrative transcriptome analysis
identifies deregulated microRNA-transcription factor networks in
lung adenocarcinoma. Oncotarget. 7:28920–28934. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tian L, Shan W, Zhang Y, Lv X, Li X and
Wei C: Up-regulation of miR-21 expression predicate advanced
clinicopathological features and poor prognosis in patients with
non-small cell lung cancer. Pathol Oncol Res. 22:161–167. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vychytilova-Faltejskova P, Radova L,
Sachlova M, Kosarova Z, Slaba K, Fabian P, Grolich T, Prochazka V,
Kala Z, Svoboda M, et al: Serum-based microRNA signatures in early
diagnosis and prognosis prediction of colon cancer. Carcinogenesis.
37:941–950. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun L, Jiang R, Li J, Wang B, Ma C, Lv Y
and Mu N: MicoRNA-425-5p is a potential prognostic biomarker for
cervical cancer. Ann Clin Biochem. 54:127–133. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang X, Du L, Duan W, Wang R, Yan K, Wang
L, Li J, Zheng G, Zhang X, Yang Y and Wang C: Serum microRNA
expression signatures as novel noninvasive biomarkers for
prediction and prognosis of muscle-invasive bladder cancer.
Oncotarget. 7:36733–36742. 2016.PubMed/NCBI
|
|
29
|
Zhu HT, Hasan AM, Liu RB, Zhang ZC, Zhang
X, Wang J, Wang HY, Wang F and Shao JY: Serum microRNA profiles as
prognostic biomarkers for HBV-positive hepatocellular carcinoma.
Oncotarget. 7:45637–45648. 2016.PubMed/NCBI
|
|
30
|
Wang ZX, Bian HB, Wang JR, Cheng ZX, Wang
KM and De W: Prognostic significance of serum miRNA-21 expression
in human non-small cell lung cancer. J Surg Oncol. 104:847–851.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ,
Wang YK, Zeng F, Zhou JH and Zhang YK: High expression of serum
miR-21 and tumor miR-200c associated with poor prognosis in
patients with lung cancer. Med Oncol. 29:618–626. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao W, Zhao JJ, Zhang L, Xu QF, Zhao YM,
Shi XY and Xu AG: Serum miR-21 level: A potential diagnostic and
prognostic biomarker for non-small cell lung cancer. Int J Clin Exp
Med. 8:14759–14763. 2015.PubMed/NCBI
|
|
33
|
Yang M, Shen H, Qiu C, Ni Y, Wang L, Dong
W, Liao Y and Du J: High expression of miR-21 and miR-155 predicts
recurrence and unfavourable survival in non-small cell lung cancer.
Eur J Cancer. 49:604–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Y, Li J, Tong L, Zhang J, Zhai A, Xu
K, Wei L and Chu M: The prognostic value of miR-21 and miR-155 in
non-small-cell lung cancer: A meta-analysis. Jpn J Clin Oncol.
43:813–820. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Munagala R, Aqil F and Gupta RC: Exosomal
miRNAs as biomarkers of recurrent lung cancer. Tumour Biol.
37:10703–10714. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Stenvold H, Donnem T, Andersen S, Al-Saad
S, Valkov A, Pedersen MI, Busund LT and Bremnes RM: High tumor cell
expression of microRNA-21 in node positive non-small cell lung
cancer predicts a favorable clinical outcome. BMC Clin Pathol.
14:92014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu R, Jiang Y, Wu Q, Li Q, Cheng D, Xu L,
Zhang C, Zhang M and Ye L: Diagnostic value of microRNA-21 in the
diagnosis of lung cancer: Evidence from a meta-analysis involving
11 studies. Tumour Biol. 35:8829–8836. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Meng X, Xiao C, Zhao Y, Jia L, Tang Y and
Li D: Meta-analysis of microarrays: Diagnostic value of microRNA-21
as a biomarker for lung cancer. Int J Biol Markers. 30:e282–e285.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tang D, Shen Y, Wang M, Yang R, Wang Z,
Sui A, Jiao W and Wang Y: Identification of plasma microRNAs as
novel noninvasive biomarkers for early detection of lung cancer.
Eur J Cancer Prev. 22:540–548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Geng Q, Fan T, Zhang B, Wang W, Xu Y and
Hu H: Five microRNAs in plasma as novel biomarkers for screening of
early-stage non-small cell lung cancer. Respir Res. 15:1492014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim JO, Gazala S, Razzak R, Guo L, Ghosh
S, Roa WH and Bedard ELR: Non-small cell lung cancer detection
using microRNA expression profiling of bronchoalveolar lavage fluid
and sputum. Anticancer Res. 35:1873–1880. 2015.PubMed/NCBI
|
|
42
|
Razzak R, Bédard EL, Kim JO, Gazala S, Guo
L, Ghosh S, Joy A, Nijjar T, Wong E and Roa WH: MicroRNA expression
profiling of sputum for the detection of early and locally advanced
non-small-cell lung cancer: A prospective case-control study. Curr
Oncol. 23:e86–e94. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang JS, Li BJ, Lu HW, Chen Y, Lu C, Zhu
RX, Liu SH, Yi QT, Li J and Song CH: Serum miR-152, miR-148a,
miR-148b, and miR-21 as novel biomarkers in non-small cell lung
cancer screening. Tumour Biol. 36:3035–3042. 2015. View Article : Google Scholar : PubMed/NCBI
|
